Milestone Pharmaceuticals Inc (MIST) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.91 (-1.35%), Market cap $0.18B, 52-week low–high $1.01 ~ $2.95.
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Financial statements, price targets, institutional (13F) holdings and related news for Milestone Pharmaceuticals Inc are updated in real time on BlackAll Trade.
Milestone Pharmaceuticals Inc trades at $0.91 (-1.35%). Real-time quotes and charts are available on BlackAll Trade.
Milestone Pharmaceuticals Inc has a market cap of about $0.18B.
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripami